The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 1.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading oversold. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it buy, with a mean price target of $27.
Central Puerto S.A.
CEPU · the NYSE · USD · Market cap $1.5B
FAIL · Does not pass the screenPrice as of 13 Nov 2026Daily close, not a live quote
Screened 2026-11-13 · the tape above runs as of 02:01 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price10.86 USD at the 13 Nov 2026 close
- Fair valueUnder review: our model's value is 2.31x the price, above our 2.00x limit.
- Our regime readMarkdown, as of 15 Nov 2026
- Ethical screenDoes not pass
- Last reviewed13 Nov 2026 (3 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-11-13).
- Trend Markdown
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Central Puerto S.A. holds its Markdown at $10.86. The statistical read favours the sellers, held for 210 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 210 days |
| Price at the screen | $10.86 |
| Valuation | 4.47 trailing · 5.83 forward price to earnings |
| Values screen | FAIL |
| Beta | -0.13 |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 23,906.44% | Below 33% | Interest-bearing debt is 23,906.4% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 16,382.66% | Below 33% | Interest-bearing cash and securities are 16,382.7% of assets, above the one-third limit. | Fail |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 2.67% | Below 5% | Only 2.7% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Central Puerto's business is in a permissible area, but its interest-bearing debt is about 23906% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when CEPU's ethical verdict changes
Today CEPU does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value under review. Our model's value is 2.31x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 5 covering, consensus Buy. The average target sits +121% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-13 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsArgentine Power Utility Trips on Debt Screen
Every time the grid hums in Buenos Aires the cash keeps flowing, yet Central Puerto still fails the one test that matters most. Revenue growth sits at 63 percent and margins reach 37 percent, but the ethical screen flags the debt ratio straight away. We pass for that reason alone, regardless of the 8.6 times forward earnings or the moderate moat.
The 19 percent return on equity and 68 percent gap to our fair value of 24 dollars might tempt some screens, yet none of those figures override the balance sheet weakness. Four analysts see a median target near 23 dollars, yet the debt load keeps the name off limits.
High leverage in a utility with currency and regulatory exposure creates real downside that cheap multiples cannot offset. The low price reflects that risk, not an opportunity. Analysis, not advice.
| Forward P/E | 5.8xcheap for a company growing this fast |
| Trailing P/E | 4.5xvery cheap relative to earnings |
| EPS, trailing | 2.28 |
| EPS, forward | 1.75 |
| Revenue growth | +224.7%growing very fast |
| Profit margin | 28.8%healthy profit margins |
| Return on equity | 19.0%a solid return on shareholder capital |
| FCF yield | -2,751.62% |
| Dividend yield | 10.58% |
| Debt to equity | 0.33minimal debt: a conservative balance sheet |
| Current ratio | 1.28adequate liquidity, worth monitoring |
| Beta | -0.13barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 9.61 - 18.50 |
| Moat | MODERATE |
| Market cap | $1.5B |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCEPU trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it buy, with a mean price target of $29.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $24.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 2.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $24.
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 5.8% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $24.
The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it strong buy, with a mean price target of $24.
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 9.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it none, with a mean price target of $22.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it none, with a mean price target of $22.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is holding around 4% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (4 analysts) rates it none, with a mean price target of $22.
Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Central Puerto: 3 Key Takeaways for Long-Term Investors Yahoo Finance · 2d ago
- Central Puerto (CEPU) Q3 2026 Earnings Call Transcript Yahoo Finance · 2d ago
- What Central Puerto (CEPU) Said on Its Q3 Earnings Call Yahoo Finance · 3d ago
- Central Puerto beats Q3 estimates with strong fuel margins Yahoo Finance · 4d ago
- 3 Undervalued Stocks To Own In October 2026 Yahoo Finance · 4 Oct 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $14.54 | +4.2% | · | $1,042 | +4.2% |
| 2 months | $16.71 | -9.3% | · | $907 | -9.3% |
| 3 months | $15.44 | -1.9% | · | $981 | -1.9% |
| 6 months | $16.51 | -8.2% | · | $918 | -8.2% |
| 1 year | $12.62 | +20.1% | · | $1,201 | +20.1% |
| 2 years | $8.91 | +70.1% | $0.35 | $1,740 | +74.0% |
| 3 years | $6.10 | +148.4% | $1.23 | $2,685 | +168.5% |
| 5 years | $2.22 | +582.2% | $1.39 | $7,448 | +644.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever CEPU does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.